Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZETA vs MRNA✓SelectedUSD · MRNAZETA vs MRNA performance historyLatest closeAs of-5.12%11/19
Stock and ETF performance explorer

ZETA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+281.8%
MRNA return
-24.9%
Excess return
+306.7%
Maximum drawdown
-70.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.1%+1.3%-6.4%-5.2%
7D-13.5%-13.8%+0.3%-12.4%
30D-4.0%-17.7%+13.7%-2.5%
3M+11.9%+14.3%-2.4%+9.3%
6M+76.1%+336.0%-259.9%+33.5%
YTD+58.3%+575.9%-517.6%+7.1%
1Y+90.9%+724.4%-633.5%+22.8%
3Y+280.4%+160.8%+119.6%+180.4%
5Y+281.8%-24.4%+306.2%+233.6%
All+281.8%-24.9%+306.7%+233.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling